Skip to main content
About
Contact
Subscribe
e-Edition
Make Home Page
Sign Up
Log In
Dashboard
Logout
My Account
Dashboard
Profile
Saved items
Logout
Facebook
Twitter
Toggle navigation
Site search
Search
Home
Contact Us
Advertise
Subscription Services
Promote Your Event
Submission Forms
News
Local News
National
World
Archives
Sports
Local Sports
National Sports
Business
Local Business
National Business
Technology
Markets & Stocks
Opinion
Columns
Editorials
Letters To The Editor
Polls
Thumbs
A & E
Local Entertainment
Art Scene
Music Scene
Theatre Scene
Book Reviews
Movie Reviews
TV Listings
Local Events
What To Do
Life
Health
Travel
Oddities
Community Directory
Community Service
Rescue Me
Other
Specials
Spring Home & Garden Show
Home & Realty
Outdoor Guide
Women
Spring on the Road
Spring Wellness
Premier Home Stylle Tour 2024
Classifieds
Place Ad
Careers
Tenders
Weather
Obituaries
2024 Auction
2024 Readersâ Choice Awards
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Nanovibronix Inc
(NQ:
NAOV
)
0.7210
UNCHANGED
Streaming Delayed Price
Updated: 3:45 PM EDT, May 10, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Press Releases about Nanovibronix Inc
< Previous
1
2
3
Next >
NanoVibronix Announces Closing of $2.4 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules
December 01, 2022
From
NanoVibronix, Inc.
Via
Business Wire
NanoVibronix Announces $2.4 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules
November 29, 2022
From
NanoVibronix, Inc.
Via
Business Wire
NanoVibronix Receives FDA 510(k) Premarket Clearance for PainShield Plus
November 28, 2022
From
NanoVibronix, Inc.
Via
Business Wire
NanoVibronix Announces Interim Results of Clinical Study for UroShield
November 16, 2022
From
NanoVibronix, Inc.
Via
Business Wire
NanoVibronix Provides Business Update in Letter to Shareholders
November 15, 2022
From
NanoVibronix, Inc.
Via
Business Wire
NanoVibronix Receives Extension to Satisfy Nasdaq Price Requirement
October 19, 2022
From
NanoVibronix, Inc.
Via
Business Wire
NanoVibronix UroShield Approved for Sale through NHS Internal Supply Chain Contract
September 23, 2022
From
NanoVibronix, Inc.
Via
Business Wire
NanoVibronix Sets Date for Annual Shareholder Meeting
September 14, 2022
From
NanoVibronix, Inc.
Via
Business Wire
NanoVibronix Announces Distribution of Series F Preferred Stock to Holders of its Common Stock
September 14, 2022
From
NanoVibronix, Inc.
Via
Business Wire
NanoVibronix Announces Receipt of Nasdaq Listing Determination; Company to Request Hearing
September 02, 2022
From
NanoVibronix, Inc.
Via
Business Wire
NanoVibronix Provides Business Update in Letter to Shareholders
August 18, 2022
From
NanoVibronix, Inc.
Via
Business Wire
NanoVibronix Announces Webinar Series to Promote UroShield
July 12, 2022
From
NanoVibronix, Inc.
Via
Business Wire
NanoVibronix Strengthening Supply Chain Increasing Efficiency and Scalability
June 29, 2022
From
NanoVibronix, Inc.
Via
Business Wire
NanoVibronix Reports First Quarter 2022 Financial Results
May 17, 2022
From
NanoVibronix, Inc.
Via
Business Wire
NanoVibronix Announces FDA 510(k) Submission for PainShield® MD PLUS
May 04, 2022
From
NanoVibronix, Inc.
Via
Business Wire
NanoVibronix Adds Additional Product to Federal Supply Schedule
April 25, 2022
From
NanoVibronix, Inc.
Via
Business Wire
NanoVibronix Advances Efforts to Achieve NHS Approval
April 05, 2022
From
NanoVibronix, Inc.
Via
Business Wire
NanoVibronix Announces PainGuard and UroGuard Approved by Health Canada as Licensed Medical Devices
March 30, 2022
From
NanoVibronix, Inc.
Via
Business Wire
NanoVibronix Added an Additional National Payer Network in Workers’ Compensation Market
February 07, 2022
From
NanoVibronix, Inc.
Via
Business Wire
NanoVibronix Extends Reach of UroShield and PainShield through MTSG’s International Network
January 24, 2022
From
NanoVibronix, Inc.
Via
Business Wire
NanoVibronix Files Three U.S. Patent Applications Further Leveraging Its Innovative Surface Acoustic Wave Technology
January 19, 2022
From
NanoVibronix, Inc.
Via
Business Wire
NanoVibronix Expands Board of Directors with Appointment of Two New Independent Directors
January 13, 2022
From
NanoVibronix, Inc.
Via
Business Wire
NanoVibronix to Present at the H.C. Wainwright BioConnect Virtual Conference
January 07, 2022
From
NanoVibronix Inc.
Via
Business Wire
NanoVibronix Further Expands VA Distribution Network to Include SDVOSB Delta Medical, LLC
January 06, 2022
From
NanoVibronix, Inc.
Via
Business Wire
NanoVibronix Selects Key Distributor to Exclusively Distribute PainShield for Veterans Administration Facilities
January 05, 2022
From
NanoVibronix, Inc.
Via
Business Wire
NanoVibronix Announces Agreement With Medina Healthcare Limited for Distribution of UroShield® and PainShield® in European Market Expansion
December 21, 2021
From
NanoVibronix Inc.
Via
Business Wire
NanoVibronix Reports Third Quarter 2021 Financial Results
November 16, 2021
From
NanoVibronix, Inc.
Via
Business Wire
SANUWAVE Inc. Assets Get Another Valuation Boost Following NanoVibronix Making Shockwave Therapy Available OTC (OTC: SNWV)
August 18, 2021
Via
AB Newswire
NanoVibronix Announces Results of Annual Meeting of Stockholders Held Today
August 17, 2021
From
NanoVibronix, Inc.
Via
Business Wire
NanoVibronix Applies for CMS Reimbursement Code for UroShield® and PainShield Plus®
August 05, 2021
From
NanoVibronix, Inc.
Via
Business Wire
< Previous
1
2
3
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.